Search results
ACER Down Despite FDA Nod for Urea Cycle Disorders Drug
Zacks via Yahoo Finance· 1 year agoThe FDA approves Acer Therapeutics' (ACER) Olpruva (sodium phenylbutyrate) to treat certain patients...
FDA Rejects Acer Therapeutics - Relief Therapeutics' Urea Cycle Disorder Candidate
Benzinga via Yahoo Finance· 2 years agoThe FDA issued a Complete Response Letter regarding the marketing application for Acer Therapeutics...
Biotech Stock Roundup: GILD's HIV Drug Approval, PRQR Surges on LLY Deal & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with many important pipeline and regulatory updates. Collaboration...
Lichenification
Verywell Health via Yahoo News· 1 year agoLesions caused by lichenification are characterized as thickened and hardened skin. This article discusses the symptoms of lichenification, its causes,...
3 Biotech Stocks for Getting Rich in 2023
InvestorPlace via Yahoo Finance· 11 months agoThe biotech industry is constantly evolving due to being on the cutting edge of the healthcare industry’s research and development. Large biotech...
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
InvestorPlace via Yahoo Finance· 7 months agoThe article embarks on a transformative journey through the biotech frontier, where the listed...
7 Micro-Cap Stocks to Buy for Risk-Taking Investors
InvestorPlace via Yahoo Finance· 1 year agoNow’s a great time to start considering which micro-cap stocks to buy. Generally, micro-caps are stocks with a market capitalization of less than $300...
